Moreover, subcutaneous injection in clinical practice usually requires continuous injection for 3–7 consecutive days and even more than 10 days, and a large amount of G-CSF injection may result in hypercoagulable blood, increasing the risk of recurrent angina or myocardial infarction [6]. This evidence concerns the gene CSF3 and myocardial infarction.